Archon Biosciences | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

---

Archon Biosciences is a biotechnology company based in Seattle, Washington, focused on developing next-generation antibody therapies through computational protein design. The company specializes in creating Antibody Cages (AbCs), which are self-assembling nanostructures that enhance the specificity and potency of biologic medicines. Their innovative approach aims to unlock therapeutic targets that traditional modalities cannot reach, supported by a team of investors and recognized scientific advancements.

🛍️ Archon Biosciences Product and Pricing News →

👔 Archon Biosciences CEO, Management and Leadership Team →

⚔️ Archon Biosciences Alternatives and Competitors →

💼 Archon Biosciences Hiring and Layoffs →

🤖 Archon Biosciences Developer, Integration and Automation News →

📈 Archon Biosciences Financials, Fundraising and Valuation News →

---

🛍️ Archon Biosciences Product and Pricing News

• Archon Biosciences is a finalist for the GeekWire Awards for Health Innovation of the Year, with results to be announced on April 30th.

---

👔 Archon Biosciences CEO, Management and Leadership Team

• James Lazarovits

  
  Co-Founder and CEO
  [email protected]

---

⚔️ Archon Biosciences Alternatives and Competitors

• Promise
|
• Etcembly
|
• SQALE
|
• Amgen
|
• Biogen
|
• CRISPR Therapeutics
|
• Molecular Partners
|
• Cradle Bio
|
• Generate Biosciences
|
• Ambrx
|
• AB Biosciences
|
• Alkira Bio
|
• Epsilico
|
• Seismic Therapeutic

---

💼 Archon Biosciences Hiring and Layoffs

---

🤖 Archon Biosciences Developer, Integration and Automation News

---

📈 Archon Biosciences Financials, Fundraising and Valuation News

• Archon Biosciences, affiliated with the University of Washington’s Institute for Protein Design, raised $20 million.

---

People also viewed

• Monod Bio
|
• Menten AI
|
• Nabla Bio
|
• Generate Biomedicines
|
• Profluent
|
• Arzeda
|
• Biomatter
|
• Latent Labs
|
• Ledger